Johnson & Johnson (JNJ) Presents at UBS Global Healthcare Conference 2025 Transcript

UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM ESTCompany ParticipantsPeter MenziusoConference ...
ophthalmologytimes

Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism

TECNIS ODYSSEY IOL, a diffractive full-range vision lens with a violet-light filter, has been implanted 100,000 times since 2024. Dr. Rocha's study showed patients tolerated up to 1.0 D of WTR ...
Hosted on MSN

Essilorluxottica’s Innovative Lens Trial: A Potential Game-Changer for Juvenile Myopia

Essilorluxottica (OTC) ((ESLOY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Hosted on MSN

Carl Zeiss Meditec’s New IOL Study: A Potential Game-Changer in Cataract Treatment

Carl Zeiss Meditec ((GB:0DHC)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...